Dolors Giralt

发表

Chemokines after human ischemic stroke: From neurovascular unit to blood using protein arrays

C. Molina, J. Montaner, A. Rosell, 2014 .

Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation

J. Montaner, K. Puttonen, J. Koistinaho, 2015, Brain, Behavior, and Immunity.

Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles

J. Montaner, A. Simats, D. Giralt, 2014, Expert review of neurotherapeutics.

Fluorescent Molecular Peroxidation Products: A Prognostic Biomarker of Early Neurologic Deterioration After Thrombolysis

C. Molina, J. Montaner, J. Álvarez-Sabín, 2014, Stroke.

VAP-1/SSAO Plasma Activity and Brain Expression in Human Hemorrhagic Stroke

J. Montaner, J. Álvarez-Sabín, M. Ribó, 2011, Cerebrovascular Diseases.

Plasmatic retinol‐binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage

J. Montaner, D. Rodríguez-Luna, M. Muchada, 2016, Journal of neurochemistry.

Plasma Matrix Metalloproteinases in Patients With Stroke During Intensive Rehabilitation Therapy.

J. Montaner, A. Rosell, S. Rodríguez, 2016, Archives of physical medicine and rehabilitation.

IL1B and VWF Variants Are Associated With Fibrinolytic Early Recanalization in Patients With Ischemic Stroke

J. Montaner, J. Martí-Fàbregas, J. Serena, 2012, Stroke.

IL 1 B and VWF Variants Are Associated With Fibrinolytic Early Recanalization in Patients With Ischemic Stroke

J. Montaner, J. Martí-Fàbregas, J. Serena, 2012 .

A predictive clinical–genetic model of tissue plasminogen activator response in acute ischemic stroke

J. Montaner, J. Martí-Fàbregas, I. Férnandez-Cadenas, 2012, Annals of neurology.

Blood markers of inflammation and endothelial dysfunction in cardioembolic stroke: systematic review and meta-analysis

J. Montaner, D. Inzitari, D. Giralt, 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients

J. Montaner, I. Férnandez-Cadenas, A. Rosell, 2011, Stroke research and treatment.

Leukoaraiosis is associated with genes regulating blood–brain barrier homeostasis in ischaemic stroke patients

C. Molina, J. Montaner, J. Álvarez-Sabín, 2011, European journal of neurology.

CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke.

C. Molina, J. Montaner, J. Álvarez-Sabín, 2010, Pharmacogenomics.

Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin)

J. Montaner, R. Delgado-Mederos, F. Moniche, 2016, Stroke.

Evidence for the efficacy of statins in animal stroke models: a meta‐analysis

D. Salat, J. Montaner, A. Rosell, 2012, Journal of neurochemistry.

Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke

C. Molina, J. Montaner, S. Kanse, 2016, International journal of stroke : official journal of the International Stroke Society.

A new method for focal transient cerebral ischaemia by distal compression of the middle cerebral artery

J. Montaner, A. Rosell, L. García‐Bonilla, 2012, Neuropathology and Applied Neurobiology.

Importance of Angiogenin and Endothelial Progenitor Cells After Rehabilitation Both in Ischemic Stroke Patients and in a Mouse Model of Cerebral Ischemia

J. Montaner, A. Rosell, S. Rodríguez, 2018, Front. Neurol..

Matrix metalloproteinase-13 participates in neuroprotection and neurorepair after cerebral ischemia in mice

J. Montaner, A. Rosell, Feifei Ma, 2016, Neurobiology of Disease.

Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells

J. Montaner, A. Rosell, M. Hernández-Guillamon, 2013, Journal of cellular and molecular medicine.

Characterization of the rat cerebrospinal fluid proteome following acute cerebral ischemia using an aptamer-based proteomic technology

J. Montaner, A. Rosell, A. Simats, 2018, Scientific Reports.

CCL23: a new CC chemokine involved in human brain damage

J. Montaner, A. Rosell, A. Rosell, 2018, Journal of internal medicine.

C‐reactive protein in the detection of post‐stroke infections: systematic review and individual participant data analysis

J. Montaner, U. Waje-Andreassen, H. Worthmann, 2017, Journal of neurochemistry.

B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis

Natalia S. Rost, Alejandro Bustamante, Karen Furie, 2015, Stroke.

The impact of post-stroke complications on in-hospital mortality depends on stroke severity

C. Molina, J. Montaner, J. Álvarez-Sabín, 2017, European stroke journal.

Immunological Biomarkers Improve the Accuracy of Clinical Risk Models of Infection in the Acute Phase of Ischemic Stroke

D. Salat, C. Molina, J. Montaner, 2013, Cerebrovascular Diseases.

Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC).

J. Montaner, F. Canals, J. Bech-Serra, 2016, Journal of proteomics.

Citicoline in pre‐clinical animal models of stroke: a meta‐analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial

J. Montaner, A. Rosell, L. García‐Bonilla, 2012, Journal of neurochemistry.

The gender gap in stroke: a meta‐analysis

J. Montaner, A. Rosell, A. Rosell, 2012, Acta neurologica Scandinavica.

NURR1 Involvement in Recombinant Tissue-Type Plasminogen Activator Treatment Complications After Ischemic Stroke

J. Montaner, I. Férnandez-Cadenas, C. Carrera, 2015, Stroke.

Merino-Zamorano et al NURR 1 ’ s Role in r-tPA Vascular Deleterious Effects 479 Thromboembolic Stroke Model

J. Montaner, I. Férnandez-Cadenas, C. Carrera, 2015 .

Dementia Rating Scale-2 normative data for middle-and older-aged Castilian speaking Spaniards

J. Montaner, J. Álvarez-Sabín, P. Delgado, 2016, The Clinical neuropsychologist.

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.

W. M. van der Flier, Carlos Cruchaga, O. Harari, 2020, Journal of Alzheimer's disease : JAD.

Changes in Body Fat Distribution in Antiretroviral-Naive HIV-Positive Individuals Initiating Current ART Regimens

D. Podzamczer, A. Imaz, D. Giralt, 2018, The Journal of clinical endocrinology and metabolism.

Lipoprotein-Associated Phospholipase A2 Activity Is Associated with Large-Artery Atherosclerotic Etiology and Recurrent Stroke in TIA Patients

J. Montaner, J. Álvarez-Sabín, A. Rosell, 2011, Cerebrovascular Diseases.

Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence.

J. Arenillas, C. Molina, J. Montaner, 2014, Atherosclerosis.

Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis

C. Sudlow, D. Tanné, J. Montaner, 2014, Journal of Neuroimmunology.

From brain to blood: New biomarkers for ischemic stroke prognosis.

J. Montaner, L. Dayon, A. Rosell, 2013, Journal of proteomics.

B-type natriuretic peptides and mortality after stroke

J. Montaner, T. Etgen, W. Whiteley, 2013, Neurology.

Role of beta‐defensin 2 and interleukin‐4 receptor as stroke outcome biomarkers

C. Molina, J. Montaner, M. Rubiera, 2014, Journal of neurochemistry.

A new method for focal transient cerebral ischaemia by distal compression of the middle cerebral artery

J. Montaner, A. Rosell, Mireia Campos-Martorell, 2012, Neuropathology and applied neurobiology.

Role of the MMP9 Gene in Hemorrhagic Transformations After Tissue-Type Plasminogen Activator Treatment in Stroke Patients

C. Molina, J. Montaner, J. Álvarez-Sabín, 2012, Stroke.

Decreased Levels of Angiogenic Growth Factors in Intracranial Atherosclerotic Disease despite Severity-Related Increase in Endothelial Progenitor Cell Counts

J. Arenillas, C. Molina, J. Montaner, 2013, Cerebrovascular Diseases.

Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study

Luis Cano, Carles Ferrer-Costa, Alejandro Bustamante, 2017, Stroke.

Impaired Vascular Remodeling after Endothelial Progenitor Cell Transplantation in MMP9-Deficient Mice Suffering Cortical Cerebral Ischemia

J. Montaner, A. Rosell, Feifei Ma, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.